7 employees
PhagePro is an early-stage biotechnology therapeutics company.
2016
$3M
from 2 investors over 2 rounds
PhagePro raised $3M on March 11, 2021
Investors: National Institutes of Health
PhagePro raised $88K on June 19, 2019
Investors: Massachusetts Life Sciences Center